Clinical Scorecard: Evaluation of Testicular Cancer Screening in Adolescents: A Nationwide Retrospective Cohort Analysis

At a Glance

Key Highlights

• Incidence rate of testicular cancer was 3.67 per 100,000 person-years among screened adolescents.
• Screening sensitivity was 66.7% at 6 months and 40% at 12 months post-examination.
• High number needed to screen (75,198 adolescents) and frequent unnecessary evaluations limit screening effectiveness.

Guideline-Based Recommendations

Diagnosis

• Screening involves physical examination by general physicians including inspection and palpation of testes.
• Suspicious findings warrant referral for ultrasonography and urologist evaluation.

Management

• Radical orchiectomy performed for confirmed testicular cancer cases.
• Most cancers diagnosed at stage I regardless of screening.

Monitoring & Follow-up

• Follow-up conducted during mandatory military service, with sensitivity analysis at 6 and 12 months post-screening.

Risks

• Low sensitivity and high number needed to screen result in frequent unnecessary ultrasounds and specialist consultations.
• Routine screening of asymptomatic adolescents is ineffective and not supported.

Patient & Prescribing Data

Over 300,000 Israeli male adolescents aged 16 to 21 years undergoing pre-military medical evaluation

Screening detected few cancers with low sensitivity; most cancers identified at early stage regardless of screening.

Clinical Best Practices

• Do not recommend routine testicular cancer screening in asymptomatic adolescent males due to low incidence and limited screening effectiveness.
• Refer only adolescents with suspicious clinical findings for further ultrasound and specialist evaluation.
• Maintain awareness of testicular cancer symptoms and encourage prompt evaluation if symptoms develop.

References

• US Preventive Services Task Force Recommendation on Testicular Cancer Screening
• American Joint Committee on Cancer Staging Manual